Investor Relations
Abcam IR Home
Share price & chart
Reports & accounts / Financial Calendar
Regulatory news (RNS)
Contacts & advisors
Governance
CSR statement
Directors
Major shareholders
Other Documents
The Abcam story
About research antibodies
Abcam company news
Main Abcam website

REG - ABCAM Plc - Total Voting Rights

 
Click for Link:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100104:nRSD9940Ea
RNS Number : 9940E
ABCAM Plc
04 January 2010
 
 
ABCAM Plc
04 January 2010 
 
 For immediate release  4 January 2010  
 
 
ABCAM PLC
("Abcam" or "the Company")
Total Voting Rights - Voting Rights and Capital
 In conformity with 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following: The
Company's issued share capital consists of 35,888,652 Ordinary Shares of 1p each with voting rights. The Company does not
hold any shares in Treasury.The above figure of 35,888,652 may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their interest in, or a change to their interest
in the Company under the FSA's Disclosure and Transparency Rules.
Date of Notification: 4 January 2010
For further information please contact: 
 
 Abcam                                              + 44 (0) 1223 696000  + 44 (0) 1223 696000    
 Jonathan Milner, Chief Executive Officer                                                         
 Jeffrey Iliffe, Chief Financial Officer                                                          
                                                                                                  
 Numis Securities                                   + 44 (0) 20 7260 1000  + 44 (0) 20 7260 1000  
 Michael Meade / Nick Westlake - Nominated Adviser                                                
 James Black - Corporate Broking                                                                  
                                                                                                  
 Buchanan Communications                            + 44 (0) 20 7466 5000  + 44 (0) 20 7466 5000  
 Mark Court / Stasa Filiplic                                                                      
 
 
Notes for editors:
About Abcam plc
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, United Kingdom, with offices
in Cambridge, Massachusetts, USA, Tokyo, Japan and Hong Kong. Abcam was admitted to AIM in November 2005 and trades under
the ticker symbol ABC. The Company produces and distributes its own and third-party produced antibodies to academic and
commercial users throughout the world. Product ordering is available through the Company's website www.abcam.com, where
customers are also able to access up-to-date and detailed technical product data sheets. All the antibodies are sold under
the Abcam brand name and the Company's vision is to build the world's largest online resource of high-quality and
commercially viable antibodies. Abcam now has an online catalogue of over 57,000 products, most of which are antibodies,
from over 250 suppliers and employs 245 staff in its four operating companies. 
This information is provided by RNS
The company news service from the London Stock Exchange 
 

---

back to RNS news